- call +1-201-465-4211
- email sales@mrinsights.biz
In Situ Hybridization (ISH)
Scope of the Report:
In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.
The worldwide market for In-Situ Hybridization is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the In-Situ Hybridization in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Radioactive isotopes
Non-radioactive labels
Market Segment by Applications, can be divided into
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
There are 15 Chapters to deeply display the global In-Situ Hybridization market.
Chapter 1, to describe In-Situ Hybridization Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of In-Situ Hybridization, with sales, revenue, and price of In-Situ Hybridization, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of In-Situ Hybridization, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, In-Situ Hybridization market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe In-Situ Hybridization sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 In-Situ Hybridization Introduction
1.2 Market Analysis by Type
1.2.1 Radioactive isotopes
1.2.2 Non-radioactive labels
1.3 Market Analysis by Applications
1.3.1 Cancer Diagnosis
1.3.2 Immunology
1.3.3 Neuroscience
1.3.4 Cytology
1.3.5 Infectious Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 In-Situ Hybridization Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 In-Situ Hybridization Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Leica Biosystems Nussloch
2.3.1 Business Overview
2.3.2 In-Situ Hybridization Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Leica Biosystems Nussloch In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Agilent Technologies
2.4.1 Business Overview
2.4.2 In-Situ Hybridization Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Agilent Technologies In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific
2.5.1 Business Overview
2.5.2 In-Situ Hybridization Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 In-Situ Hybridization Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PerkinElmer
2.7.1 Business Overview
2.7.2 In-Situ Hybridization Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PerkinElmer In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Exiqon A/S
2.8.1 Business Overview
2.8.2 In-Situ Hybridization Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Exiqon A/S In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 BioGenex Laboratories
2.9.1 Business Overview
2.9.2 In-Situ Hybridization Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BioGenex Laboratories In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Advanced Cell Diagnostics
2.10.1 Business Overview
2.10.2 In-Situ Hybridization Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Advanced Cell Diagnostics In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bio SB
2.11.1 Business Overview
2.11.2 In-Situ Hybridization Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bio SB In-Situ Hybridization Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global In-Situ Hybridization Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global In-Situ Hybridization Sales and Market Share by Manufacturer (2016-2017)
3.2 Global In-Situ Hybridization Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 In-Situ Hybridization Manufacturer Market Share in 2017
3.3.2 Top 6 In-Situ Hybridization Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global In-Situ Hybridization Market Analysis by Regions
4.1 Global In-Situ Hybridization Sales, Revenue and Market Share by Regions
4.1.1 Global In-Situ Hybridization Sales and Market Share by Regions (2013-2018)
4.1.2 Global In-Situ Hybridization Revenue and Market Share by Regions (2013-2018)
4.2 North America In-Situ Hybridization Sales and Growth Rate (2013-2018)
4.3 Europe In-Situ Hybridization Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific In-Situ Hybridization Sales and Growth Rate (2013-2018)
4.5 South America In-Situ Hybridization Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa In-Situ Hybridization Sales and Growth Rate (2013-2018)
5 North America In-Situ Hybridization by Countries
5.1 North America In-Situ Hybridization Sales, Revenue and Market Share by Countries
5.1.1 North America In-Situ Hybridization Sales and Market Share by Countries (2013-2018)
5.1.2 North America In-Situ Hybridization Revenue and Market Share by Countries (2013-2018)
5.2 United States In-Situ Hybridization Sales and Growth Rate (2013-2018)
5.3 Canada In-Situ Hybridization Sales and Growth Rate (2013-2018)
5.4 Mexico In-Situ Hybridization Sales and Growth Rate (2013-2018)
6 Europe In-Situ Hybridization by Countries
6.1 Europe In-Situ Hybridization Sales, Revenue and Market Share by Countries
6.1.1 Europe In-Situ Hybridization Sales and Market Share by Countries (2013-2018)
6.1.2 Europe In-Situ Hybridization Revenue and Market Share by Countries (2013-2018)
6.2 Germany In-Situ Hybridization Sales and Growth Rate (2013-2018)
6.3 UK In-Situ Hybridization Sales and Growth Rate (2013-2018)
6.4 France In-Situ Hybridization Sales and Growth Rate (2013-2018)
6.5 Russia In-Situ Hybridization Sales and Growth Rate (2013-2018)
6.6 Italy In-Situ Hybridization Sales and Growth Rate (2013-2018)
7 Asia-Pacific In-Situ Hybridization by Countries
7.1 Asia-Pacific In-Situ Hybridization Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific In-Situ Hybridization Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific In-Situ Hybridization Revenue and Market Share by Countries (2013-2018)
7.2 China In-Situ Hybridization Sales and Growth Rate (2013-2018)
7.3 Japan In-Situ Hybridization Sales and Growth Rate (2013-2018)
7.4 Korea In-Situ Hybridization Sales and Growth Rate (2013-2018)
7.5 India In-Situ Hybridization Sales and Growth Rate (2013-2018)
7.6 Southeast Asia In-Situ Hybridization Sales and Growth Rate (2013-2018)
8 South America In-Situ Hybridization by Countries
8.1 South America In-Situ Hybridization Sales, Revenue and Market Share by Countries
8.1.1 South America In-Situ Hybridization Sales and Market Share by Countries (2013-2018)
8.1.2 South America In-Situ Hybridization Revenue and Market Share by Countries (2013-2018)
8.2 Brazil In-Situ Hybridization Sales and Growth Rate (2013-2018)
8.3 Argentina In-Situ Hybridization Sales and Growth Rate (2013-2018)
8.4 Colombia In-Situ Hybridization Sales and Growth Rate (2013-2018)
9 Middle East and Africa In-Situ Hybridization by Countries
9.1 Middle East and Africa In-Situ Hybridization Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa In-Situ Hybridization Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa In-Situ Hybridization Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia In-Situ Hybridization Sales and Growth Rate (2013-2018)
9.3 UAE In-Situ Hybridization Sales and Growth Rate (2013-2018)
9.4 Egypt In-Situ Hybridization Sales and Growth Rate (2013-2018)
9.5 Nigeria In-Situ Hybridization Sales and Growth Rate (2013-2018)
9.6 South Africa In-Situ Hybridization Sales and Growth Rate (2013-2018)
10 Global In-Situ Hybridization Market Segment by Type
10.1 Global In-Situ Hybridization Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global In-Situ Hybridization Sales and Market Share by Type (2013-2018)
10.1.2 Global In-Situ Hybridization Revenue and Market Share by Type (2013-2018)
10.2 Radioactive isotopes Sales Growth and Price
10.2.1 Global Radioactive isotopes Sales Growth (2013-2018)
10.2.2 Global Radioactive isotopes Price (2013-2018)
10.3 Non-radioactive labels Sales Growth and Price
10.3.1 Global Non-radioactive labels Sales Growth (2013-2018)
10.3.2 Global Non-radioactive labels Price (2013-2018)
11 Global In-Situ Hybridization Market Segment by Application
11.1 Global In-Situ Hybridization Sales Market Share by Application (2013-2018)
11.2 Cancer Diagnosis Sales Growth (2013-2018)
11.3 Immunology Sales Growth (2013-2018)
11.4 Neuroscience Sales Growth (2013-2018)
11.5 Cytology Sales Growth (2013-2018)
11.6 Infectious Diseases Sales Growth (2013-2018)
12 In-Situ Hybridization Market Forecast (2018-2023)
12.1 Global In-Situ Hybridization Sales, Revenue and Growth Rate (2018-2023)
12.2 In-Situ Hybridization Market Forecast by Regions (2018-2023)
12.2.1 North America In-Situ Hybridization Market Forecast (2018-2023)
12.2.2 Europe In-Situ Hybridization Market Forecast (2018-2023)
12.2.3 Asia-Pacific In-Situ Hybridization Market Forecast (2018-2023)
12.2.4 South America In-Situ Hybridization Market Forecast (2018-2023)
12.2.5 Middle East and Africa In-Situ Hybridization Market Forecast (2018-2023)
12.3 In-Situ Hybridization Market Forecast by Type (2018-2023)
12.3.1 Global In-Situ Hybridization Sales Forecast by Type (2018-2023)
12.3.2 Global In-Situ Hybridization Market Share Forecast by Type (2018-2023)
12.4 In-Situ Hybridization Market Forecast by Application (2018-2023)
12.4.1 Global In-Situ Hybridization Sales Forecast by Application (2018-2023)
12.4.2 Global In-Situ Hybridization Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure In-Situ Hybridization Picture
Table Product Specifications of In-Situ Hybridization
Figure Global Sales Market Share of In-Situ Hybridization by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
